News

New York Biotech Industry is on the Rise

New York Biotech Destination

Overview

Adam Volini, executive director and VP of Life Science & Strategic Partnerships at Empire State Development shares New York’s ambitious future and how the state is emerging as a competitive US biotech hub.

The Big Picture

The Bolstering Biotech Initiative adds $65 million on top of a 2017 $620 million investment that’s already generated roughly $6 billion in value. Add Biogenesis Park’s 550,000-square-foot Long Island campus and upstate momentum from Micron’s semiconductor buildout, and the state’s ecosystem is scaling fast — from R&D to manufacturing. For companies navigating this growth, New York Bio Connect is the natural resource: a single hub for the connections, funding intelligence, and infrastructure updates the industry needs to keep pace.

Read the article
Next up:

Events